A nuclear export signal within the structural Gag protein is required for prototype foamy virus replication

Retrovirology

Volumn 8, Issue , 2011, Pages

  Renault, Noémie ^a   Tobaly Tapiero, Joelle ^a   Paris, Joris ^a   Giron, Marie Lou ^a   Coiffic, Audrey ^a   Roingeard, Philippe ^b   Saïb, Ali ^a,c  

^a CNRS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c Bioinformatique et Chimie Moléculaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS RNA; HYBRID PROTEIN; LEPTOMYCIN B; REV PROTEIN; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS-1; UNSATURATED FATTY ACID;

AMINO TERMINAL SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEAR EXPORT SIGNAL; POINT MUTATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SPUMA VIRUS; STRUCTURE ANALYSIS; VIRUS CAPSID; VIRUS MUTANT; VIRUS RELEASE; VIRUS REPLICATION; VIRUS VIRULENCE; WILD TYPE; CELL NUCLEUS; CELL STRAIN HEK293; CHEMISTRY; GENETICS; HELA CELL; HUMAN; METABOLISM; PHYSIOLOGY; SIMIAN FOAMY VIRUS; SITE DIRECTED MUTAGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN SPUMARETROVIRUS; MIRIDAE;

CELL NUCLEUS; FATTY ACIDS, UNSATURATED; GENE PRODUCTS, GAG; HEK293 CELLS; HELA CELLS; HIV-1; HUMANS; MUTAGENESIS, SITE-DIRECTED; NUCLEAR EXPORT SIGNALS; POINT MUTATION; RECOMBINANT FUSION PROTEINS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN FOAMY VIRUS; VIRUS REPLICATION;

EID: 78651592504     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-8-6     Document Type: Article

References (61)

1. Freed EO. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 1998, 251:1-15. 10.1006/viro.1998.9398, 9813197.
2. Ganser-Pornillos BK, Yeager M, Sundquist WI. The structural biology of HIV assembly. Curr Opin Struct Biol 2008, 18:203-217. 10.1016/j.sbi.2008.02.001, 2819415, 18406133.
3. Martin-Serrano J. The role of ubiquitin in retroviral egress. Traffic 2007, 8:1297-1303. 10.1111/j.1600-0854.2007.00609.x, 17645437.
4. Morita E, Sundquist WI. Retrovirus budding. Annu Rev Cell Dev Biol 2004, 20:395-425. 10.1146/annurev.cellbio.20.010403.102350, 15473846.
5. Klein KC, Reed JC, Lingappa JR. Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag. AIDS Rev 2007, 9:150-161.
6. Delelis O, Lehmann-Che J, Saib A. Foamy viruses - a world apart. Curr Opin Microbiol 2004, 7:400-406. 10.1016/j.mib.2004.06.009, 15358259.
7. Yu SF, Baldwin DN, Gwynn SR, Yendapalli S, Linial ML. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 1996, 271:1579-1582. 10.1126/science.271.5255.1579, 8599113.
8. Flugel RM, Pfrepper KI. Proteolytic processing of foamy virus Gag and Pol proteins. Curr Top Microbiol Immunol 2003, 277:63-88.
9. Yu SF, Edelmann K, Strong RK, Moebes A, Rethwilm A, Linial ML. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J Virol 1996, 70:8255-8262. 190912, 8970944.
10. Stenbak CR, Linial ML. Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression. J Virol 2004, 78:9423-9430. 10.1128/JVI.78.17.9423-9430.2004, 506921, 15308736.
11. Schliephake AW, Rethwilm A. Nuclear localization of foamy virus Gag precursor protein. J Virol 1994, 68:4946-4954. 236435, 8035493.
12. Imrich H, Heinkelein M, Herchenroder O, Rethwilm A. Primate foamy virus Pol proteins are imported into the nucleus. J Gen Virol 2000, 81:2941-2947.
13. Meiering CD, Comstock KE, Linial ML. Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells. J Virol 2000, 74:1718-1726. 10.1128/JVI.74.4.1718-1726.2000, 111647, 10644342.
14. Tobaly-Tapiero J, Bittoun P, Lehmann-Che J, Delelis O, Giron ML, De The H, Saib A. Chromatin tethering of incoming foamy virus by the structural Gag protein. Traffic 2008, 9:1717-27. 10.1111/j.1600-0854.2008.00792.x, 18627573.
15. Lee AH, Lee HY, Sung YC. The gene expression of human foamy virus does not require a post-transcriptional transactivator. Virology 1994, 204:409-413. 10.1006/viro.1994.1545, 7522374.
16. Sfakianos JN, LaCasse RA, Hunter E. The M-PMV Cytoplasmic Targeting-Retention Signal Directs Nascent Gag Polypeptides to a Pericentriolar Region of the Cell. Traffic 2003, 4:660-670. 10.1034/j.1600-0854.2003.00125.x, 12956869.
17. Yu SF, Eastman SW, Linial ML. Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag. Traffic 2006, 7:966-977. 10.1111/j.1600-0854.2006.00448.x, 16749903.
18. Eastman SW, Linial ML. Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J Virol 2001, 75:6857-6864. 10.1128/JVI.75.15.6857-6864.2001, 114413, 11435565.
19. Choi G, Park S, Choi B, Hong S, Lee J, Hunter E, Rhee SS. Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein. J Virol 1999, 73:5431-5437. 112599, 10364290.
20. Lindemann D, Pietschmann T, Picard-Maureau M, Berg A, Heinkelein M, Thurow J, Knaus P, Zentgraf H, Rethwilm A. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol 2001, 75:5762-5771. 10.1128/JVI.75.13.5762-5771.2001, 114292, 11390578.
21. Patton GS, Morris SA, Chung W, Bieniasz PD, McClure MO. Identification of domains in gag important for prototypic foamy virus egress. J Virol 2005, 79:6392-6399. 10.1128/JVI.79.10.6392-6399.2005, 1091687, 15858022.
22. Stange A, Mannigel I, Peters K, Heinkelein M, Stanke N, Cartellieri M, Gottlinger H, Rethwilm A, Zentgraf H, Lindemann D. Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J Virol 2005, 79:5466-5476. 10.1128/JVI.79.9.5466-5476.2005, 1082757, 15827161.
23. Stange A, Luftenegger D, Reh J, Weissenhorn W, Lindemann D. Subviral particle release determinants of prototype foamy virus. J Virol 2008, 82:9858-9869. 10.1128/JVI.00949-08, 2566296, 18684814.
24. Petit C, Giron ML, Tobaly-Tapiero J, Bittoun P, Real E, Jacob Y, Tordo N, De The H, Saib A. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. J Cell Sci 2003, 116:3433-3442. 10.1242/jcs.00613, 12857789.
25. Saib A, Puvion-Dutilleul F, Schmid M, Peries J, de The H. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J Virol 1997, 71:1155-1161. 191168, 8995637.
26. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M, Hope TJ. Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002, 159:441-452. 10.1083/jcb.200203150, 2173076, 12417576.
27. Dupont S, Sharova N, DeHoratius C, Virbasius CM, Zhu X, Bukrinskaya AG, Stevenson M, Green MR. A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature 1999, 402:681-685. 10.1038/45272, 10604476.
28. Scheifele LZ, Garbitt RA, Rhoads JD, Parent LJ. Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc Natl Acad Sci USA 2002, 99:3944-3949. 10.1073/pnas.062652199, 122628, 11891341.
29. Garbitt-Hirst R, Kenney SP, Parent LJ. Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging. J Virol 2009, 83:6790-6797. 10.1128/JVI.00101-09, 2698546, 19369339.
30. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001, 11:725-732. 10.1016/S0959-440X(01)00266-4, 11751054.
31. Kutay U, Guttinger S. Leucine-rich nuclear-export signals: born to be weak. Trends Cell Biol 2005, 15:121-124. 10.1016/j.tcb.2005.01.005, 15752974.
32. Neville M, Stutz F, Lee L, Davis LI, Rosbash M. The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr Biol 1997, 7:767-775. 10.1016/S0960-9822(06)00335-6, 9368759.
33. Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B, Yoshida M, Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci USA 1999, 96:9112-9117. 10.1073/pnas.96.16.9112, 17741, 10430904.
34. Kudo N, Wolff B, Sekimoto T, Schreiner EP, Yoneda Y, Yanagida M, Horinouchi S, Yoshida M. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res 1998, 242:540-547. 10.1006/excr.1998.4136, 9683540.
35. Wolff B, Sanglier J, Wang Y. Leptomycin B is an inhibitor of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol 1997, 4:139-147. 10.1016/S1074-5521(97)90257-X, 9190288.
36. Cartellieri M, Herchenroder O, Rudolph W, Heinkelein M, Lindemann D, Zentgraf H, Rethwilm A. N-terminal Gag domain required for foamy virus particle assembly and export. J Virol 2005, 79:12464-12476. 10.1128/JVI.79.19.12464-12476.2005, 1211529, 16160174.
37. Lehmann-Che J, Giron ML, Delelis O, Lochelt M, Bittoun P, Tobaly-Tapiero J, de The H, Saib A. Protease-dependent uncoating of a complex retrovirus. J Virol 2005, 79:9244-9253. 10.1128/JVI.79.14.9244-9253.2005, 1168774, 15994819.
38. la Cour T, Kiemer L, Molgaard A, Gupta R, Skriver K, Brunak S. Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel 2004, 17:527-536. 10.1093/protein/gzh062, 15314210.
39. Tobaly-Tapiero J, Bittoun P, Giron ML, Neves M, Koken M, de The H, Saib A. Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag. J Virol 2001, 75:4367-4375. 10.1128/JVI.75.9.4367-4375.2001, 114181, 11287585.
40. Balasundaram D, Benedik MJ, Morphew M, Dang VD, Levin HL. Nup124p is a nuclear pore factor of Schizosaccharomyces pombe that is important for nuclear import and activity of retrotransposon Tf1. Mol Cell Biol 1999, 19:5768-5784. 84427, 10409764.
41. Kenney SP, Lochmann TL, Schmid CL, Parent LJ. Intermolecular interactions between retroviral Gag proteins in the nucleus. J Virol 2008, 82:683-691. 10.1128/JVI.02049-07, 2224582, 17977961.
42. Malim MH, Freimuth WW, Liu J, Boyle TJ, Lyerly HK, Cullen BR, Nabel GJ. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J Exp Med 1992, 176:1197-1201. 10.1084/jem.176.4.1197, 2119391, 1402661.
43. Szilvay AM, Brokstad KA, Kopperud R, Haukenes G, Kalland KH. Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. J Virol 1995, 69:3315-3323. 189043, 7745679.
44. Szilvay AM, Boe SO, Kalland KH. Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs. J Gen Virol 1999, 80(Pt 8):1965-1974.
45. Trono D, Feinberg MB, Baltimore D. HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 1989, 59:113-120. 10.1016/0092-8674(89)90874-X, 2676192.
46. Mannigel I, Stange A, Zentgraf H, Lindemann D. Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J Virol 2007, 81:3317-3326. 10.1128/JVI.01866-06, 1866044, 17229703.
47. Terry LJ, Shows EB, Wente SR. Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 2007, 318:1412-1416. 10.1126/science.1142204, 18048681.
48. Cullen BR. Nuclear mRNA export: insights from virology. Trends Biochem Sci 2003, 28:419-424. 10.1016/S0968-0004(03)00142-7, 12932730.
49. Swanson CM, Malim MH. Retrovirus RNA trafficking: from chromatin to invasive genomes. Traffic 2006, 7:1440-1450. 10.1111/j.1600-0854.2006.00488.x, 16984406.
50. Caporale M, Arnaud F, Mura M, Golder M, Murgia C, Palmarini M. The signal peptide of a simple retrovirus envelope functions as a posttranscriptional regulator of viral gene expression. J Virol 2009, 83:4591-4604. 10.1128/JVI.01833-08, 2668452, 19244321.
51. Muriaux D, Mirro J, Harvin D, Rein A. RNA is a structural element in retrovirus particles. Proc Natl Acad Sci USA 2001, 98:5246-5251. 10.1073/pnas.091000398, 33195, 11320254.
52. Scheifele LZ, Kenney SP, Cairns TM, Craven RC, Parent LJ. Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology. J Virol 2007, 81:10718-10728. 10.1128/JVI.01061-07, 2045444, 17634229.
53. Gudleski N, Flanagan JM, Ryan EP, Bewley MC, Parent LJ. Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA. Proc Natl Acad Sci USA 2010, 107:9358-9363. 10.1073/pnas.1000304107, 2889109, 20435918.
54. LeBlanc JJ, Uddowla S, Abraham B, Clatterbuck S, Beemon KL. Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA. Virology 2007, 363:376-386. 10.1016/j.virol.2007.01.026, 2564995, 17328934.
55. Jin J, Sturgeon T, Chen C, Watkins SC, Weisz OA, Montelaro RC. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays. J Virol 2007, 81:11226-11235. 10.1128/JVI.00431-07, 2045577, 17686839.
56. Butsch M, Boris-Lawrie K. Destiny of unspliced retroviral RNA: ribosome and/or virion?. J Virol 2002, 76:3089-3094. 10.1128/JVI.76.7.3089-3094.2002, 136024, 11884533.
57. Sherer NM, Swanson CM, Papaioannou S, Malim MH. Matrix Mediates the Functional Link between Hiv-1 Rna Nuclear Export Elements and Gag Assembly Competency in Murine Cells. J Virol 2009, 83:8525-35. 10.1128/JVI.00699-09, 2738188, 19535446.
58. Swanson CM, Puffer BA, Ahmad KM, Doms RW, Malim MH. Retroviral mRNA nuclear export elements regulate protein function and virion assembly. Embo J 2004, 23:2632-2640. 10.1038/sj.emboj.7600270, 449780, 15201866.
59. Bodem J, Zemba M, Flugel RM. Nuclear localization of the functional Bel 1 transactivator but not of the gag proteins of the feline foamy virus. Virology 1998, 251:22-27. 10.1006/viro.1998.9369, 9813199.
60. Rethwilm A. Molecular biology of foamy viruses. Med Microbiol Immunol 2010, 199:197-207. 10.1007/s00430-010-0158-x, 20445989.
61. Bodem J, Schied T, Gabriel R, Rammling M, Rethwilm A. Foamy viral nuclear RNA-export is distinct from other retroviruses. J Virol 2010, [Epub ahead of print].